From from From
: : :
david david david
@ @ @
stat stat stat
. . .
com com com
( ( (
David david David
Dodell dodel Dodell
) ) )
Subject subject Subject
: : :
HICN hicn HICN
611 611 611
Medical medic Medical
News news News
Part part Part
1 1 1
/ / /
4 4 4
Reply repli Reply
- - -
To to To
: : :
david david david
@ @ @
stat stat stat
. . .
com com com
( ( (
David david David
Dodell dodel Dodell
) ) )
Distribution distribut Distribution
: : :
world world world
Organization organ Organization
: : :
Stat stat Stat
Gateway gateway Gateway
Service servic Service
, , ,
WB wb WB
7 7 7
TPY tpi TPY
Lines line Lines
: : :
707 707 707
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
cut cut cut
here here here
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
+ + +
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
+ + +
! ! !
! ! !
! ! !
Health health Health
Info info Info
- - -
Com com Com
Network network Network
! ! !
! ! !
Medical medic Medical
Newsletter newslett Newsletter
! ! !
+ + +
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
+ + +
Editor editor Editor
: : :
David david David
Dodell dodel Dodell
, , ,
D d D
. . .
M m M
. . .
D d D
. . .
10250 10250 10250
North north North
92 92 92
nd nd nd
Street street Street
, , ,
Suite suit Suite
210 210 210
, , ,
Scottsdale scottsdal Scottsdale
, , ,
Arizona arizona Arizona
85258 85258 85258
- - -
4599 4599 4599
USA usa USA
Telephone telephon Telephone
+ + +
1 1 1
( ( (
602 602 602
) ) )
860 860 860
- - -
1121 1121 1121
FAX fax FAX
+ + +
1 1 1
( ( (
602 602 602
) ) )
451 451 451
- - -
1165 1165 1165
Compilation compil Compilation
Copyright copyright Copyright
1993 1993 1993
by by by
David david David
Dodell dodel Dodell
, , ,
D d D
. . .
M m M
. . .
D d D
. . .
All all All
rights right right
Reserved reserv Reserved
. . .
License licens License
is is be
hereby herebi hereby
granted grant grant
to to to
republish republish republish
on on on
electronic electron electronic
media media medium
for for for
which which which
no no no
fees fee fee
are are be
charged charg charge
, , ,
so so so
long long long
as as a
the the the
text text text
of of of
this this this
copyright copyright copyright
notice notic notice
and and and
license licens license
are are be
attached attach attach
intact intact intact
to to to
any ani any
and and and
all all all
republished republish republish
portion portion portion
or or or
portions portion portion
. . .
The the The
Health health Health
Info info Info
- - -
Com com Com
Network network Network
Newsletter newslett Newsletter
is is be
distributed distribut distribute
biweekly biweek biweekly
. . .
Articles articl Articles
on on on
a a a
medical medic medical
nature natur nature
are are be
welcomed welcom welcome
. . .
If if If
you you you
have have have
an an an
article articl article
, , ,
please pleas please
contact contact contact
the the the
editor editor editor
for for for
information inform information
on on on
how how how
to to to
submit submit submit
it it it
. . .
If if If
you you you
are are be
interested interest interested
in in in
joining join join
the the the
automated autom automate
distribution distribut distribution
system system system
, , ,
please pleas please
contact contact contact
the the the
editor editor editor
. . .
E e E
- - -
Mail mail Mail
Address address Address
: : :
Editor editor Editor
: : :
Internet internet Internet
: : :
david david david
@ @ @
stat stat stat
. . .
com com com
FidoNet fidonet FidoNet
= = =
1 1 1
: : :
114 114 114
/ / /
15 15 15
Bitnet bitnet Bitnet
= = =
ATW atw ATW
1 1 1
H h H
@ @ @
ASUACAD asuacad ASUACAD
LISTSERV listserv LISTSERV
= = =
MEDNEWS mednew MEDNEWS
@ @ @
ASUACAD asuacad ASUACAD
. . .
BITNET bitnet BITNET
( ( (
or or or
internet internet internet
: : :
mednews mednew mednews
@ @ @
asuvm asuvm asuvm
. . .
inre inr inre
. . .
asu asu asu
. . .
edu edu edu
) ) )
anonymous anonym anonymous
ftp ftp ftp
= = =
vm vm vm
1 1 1
. . .
nodak nodak nodak
. . .
edu edu edu
Notification notif Notification
List list List
= = =
hicn hicn hicn
- - -
notify notifi notify
- - -
request request request
@ @ @
stat stat stat
. . .
com com com
FAX fax FAX
Delivery deliveri Delivery
= = =
Contact contact Contact
Editor editor Editor
for for for
information inform information
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
T t T
A a A
B b B
L l L
E e E
O o O
F f F
C c C
O o O
N n N
T t T
E e E
N n N
T t T
S s S
1 1 1
. . .
Centers center Centers
for for for
Disease diseas Disease
Control control Control
and and and
Prevention prevent Prevention
- - -
MMWR mmwr MMWR
[ [ [
23 23 23
April april April
1993 1993 1993
] ] ]
Rates rate Rates
of of of
Cesarean cesarean Cesarean
Delivery deliveri Delivery
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
1 1 1
Malaria malaria Malaria
Among among Among
U u U
. . .
S s S
. . .
Embassy embassi Embassy
Personnel personnel Personnel
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
5 5 5
FDA fda FDA
Approval approv Approval
of of of
Hib hib Hib
Vaccine vaccin Vaccine
for for for
Children children Children
/ / /
Infants infant Infants
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
8 8 8
2 2 2
. . .
Dental dental Dental
News news News
Workshop workshop Workshop
Explores explor Explores
Oral oral Oral
Manifestations manifest Manifestations
of of of
HIV hiv HIV
Infection infect Infection
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
11 11 11
3 3 3
. . .
Food food Food
& & &
Drug drug Drug
Administration administr Administration
News news News
FDA fda FDA
Approves approv Approves
Depo depo Depo
Provera provera Provera
, , ,
injectable inject injectable
contraceptive contracept contraceptive
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
14 14 14
New new New
Rules rule Rules
Speed speed Speed
Approval approv Approval
of of of
Drugs drug Drugs
for for for
Life life Life
- - -
Threatening threaten Threatening
Illnesses ill Illnesses
. . .
. . .
. . .
. . .
. . .
16 16 16
4 4 4
. . .
Articles articl Articles
Research research Research
Promises promis Promises
Preventing prevent Preventing
/ / /
Slowing slow Slowing
Blindness blind Blindness
from from from
Retinal retin Retinal
Disease diseas Disease
. . .
. . .
18 18 18
Affluent affluent Affluent
Diet diet Diet
Increases increas Increases
Risk risk Risk
Of of Of
Heart heart Heart
Disease diseas Disease
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
20 20 20
5 5 5
. . .
General general General
Announcments announc Announcments
Publications public Publications
for for for
Health health Health
Professionals profession Professionals
from from from
National nation National
Cancer cancer Cancer
Institute institut Institute
. . .
23 23 23
Publications public Publications
for for for
Patients patient Patients
Available avail Available
from from from
National nation National
Cancer cancer Cancer
Institute institut Institute
. . .
. . .
. . .
30 30 30
6 6 6
. . .
AIDS aid AIDS
News news News
Summaries summari Summaries
AIDS aid AIDS
Daily daili Daily
Summary summari Summary
for for for
April april April
19 19 19
to to to
April april April
23 23 23
, , ,
1993 1993 1993
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
38 38 38
7 7 7
. . .
AIDS aid AIDS
Statistics statist Statistics
Worldwide worldwid Worldwide
AIDS aid AIDS
Statistics statist Statistics
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
48 48 48
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
i i i
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
Centers center Centers
for for for
Disease diseas Disease
Control control Control
and and and
Prevention prevent Prevention
- - -
MMWR mmwr MMWR
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
Rates rate Rates
of of of
Cesarean cesarean Cesarean
Delivery deliveri Delivery
- - -
- - -
United unit United
States state States
, , ,
1991 1991 1991
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
SOURCE sourc SOURCE
: : :
MMWR mmwr MMWR
42 42 42
( ( (
15 15 15
) ) )
DATE date DATE
: : :
Apr apr Apr
23 23 23
, , ,
1993 1993 1993
Cesarean cesarean Cesarean
deliveries deliveri delivery
have have have
accounted account account
for for for
nearly near nearly
1 1 1
million million million
of of of
the the the
approximately approxim approximately
4 4 4
million million million
annual annual annual
deliveries deliveri delivery
in in in
the the the
United unit United
States state States
since sinc since
1986 1986 1986
( ( (
Table tabl Table
1 1 1
) ) )
. . .
The the The
cesarean cesarean cesarean
rate rate rate
in in in
the the the
United unit United
States state States
is is be
the the the
third third third
highest highest high
among among among
21 21 21
reporting report report
countries countri country
, , ,
exceeded exceed exceed
only onli only
by by by
Brazil brazil Brazil
and and and
Puerto puerto Puerto
Rico rico Rico
( ( (
1 1 1
) ) )
. . .
This this This
report report report
presents present present
data data data
on on on
cesarean cesarean cesarean
deliveries deliveri delivery
from from from
CDC cdc CDC
' ' '
s s s
National nation National
Hospital hospit Hospital
Discharge discharg Discharge
Survey survey Survey
( ( (
NHDS nhds NHDS
) ) )
for for for
1991 1991 1991
and and and
compares compar compare
these these these
data data data
with with with
previous previous previous
years year year
. . .
Data data Data
on on on
discharges discharg discharge
from from from
short short short
- - -
stay stay stay
, , ,
nonfederal nonfeder nonfederal
hospitals hospit hospital
have have have
been been be
collected collect collect
annually annual annually
since sinc since
1965 1965 1965
in in in
the the the
NHDS nhds NHDS
, , ,
conducted conduct conduct
by by by
CDC cdc CDC
' ' '
s s s
National nation National
Center center Center
for for for
Health health Health
Statistics statist Statistics
. . .
For for For
1991 1991 1991
, , ,
medical medic medical
and and and
demographic demograph demographic
information inform information
were were be
abstracted abstract abstract
from from from
a a a
sample sampl sample
of of of
274 274 274
, , ,
000 000 000
inpatients inpati inpatient
discharged discharg discharge
from from from
484 484 484
participating particip participate
hospitals hospit hospital
. . .
The the The
1991 1991 1991
cesareans cesarean cesarean
and and and
vaginal vagin vaginal
births birth birth
after after after
a a a
prior prior prior
cesarean cesarean cesarean
( ( (
VBAC vbac VBAC
) ) )
presented present present
in in in
this this this
report report report
are are be
based base base
on on on
weighted weight weighted
national nation national
estimates estim estimate
from from from
the the the
NHDS nhds NHDS
sample sampl sample
of of of
approximately approxim approximately
31 31 31
, , ,
000 000 000
( ( (
11 11 11
% % %
) ) )
women women woman
discharged discharg discharge
after after after
delivery deliveri delivery
. . .
The the The
estimated estim estimated
numbers number number
of of of
live live live
births birth birth
by by by
type type type
of of of
delivery deliveri delivery
were were be
calculated calcul calculate
by by by
applying appli apply
cesarean cesarean cesarean
rates rate rate
from from from
the the the
NHDS nhds NHDS
to to to
live live live
births birth birth
from from from
national nation national
vital vital vital
registration registr registration
data data data
. . .
Therefore therefor Therefore
, , ,
estimates estim estimate
of of of
the the the
number number number
of of of
cesareans cesarean cesarean
in in in
this this this
report report report
will will will
not not not
agree agre agree
with with with
previously previous previously
published publish publish
data data data
based base base
solely sole solely
on on on
the the the
NHDS nhds NHDS
( ( (
2 2 2
) ) )
. . .
Stated state Stated
differences differ difference
in in in
this this this
analysis analysi analysis
are are be
significant signific significant
at at at
the the the
95 95 95
% % %
confidence confid confidence
level level level
, , ,
based base base
on on on
the the the
two two two
- - -
tailed tail tail
t t t
- - -
test test test
with with with
a a a
critical critic critical
value valu value
of of of
1 1 1
. . .
96 96 96
. . .
In in In
1991 1991 1991
, , ,
there there there
were were be
23 23 23
. . .
5 5 5
cesareans cesarean cesarean
per per per
100 100 100
deliveries deliveri delivery
, , ,
the the the
same same same
rate rate rate
as as a
in in in
1990 1990 1990
and and and
similar similar similar
to to to
rates rate rate
during dure during
1986 1986 1986
- - -
1989 1989 1989
( ( (
Table tabl Table
1 1 1
) ) )
. . .
The the The
primary primari primary
cesarean cesarean cesarean
rate rate rate
( ( (
i i i
. . .
e e e
. . .
, , ,
number number number
of of of
first first first
cesareans cesarean cesarean
per per per
100 100 100
deliveries deliveri delivery
to to to
women women woman
who who who
had had have
no no no
previous previous previous
cesareans cesarean cesarean
) ) )
for for for
1986 1986 1986
- - -
1991 1991 1991
also also also
was was be
stable stabl stable
, , ,
ranging rang range
from from from
16 16 16
. . .
8 8 8
to to to
17 17 17
. . .
5 5 5
. . .
In in In
1991 1991 1991
, , ,
the the the
cesarean cesarean cesarean
rate rate rate
in in in
the the the
South south South
was was be
27 27 27
. . .
6 6 6
, , ,
significantly signific significantly
( ( (
p p p
< < <
0 0 0
. . .
05 05 05
) ) )
higher higher high
than than than
the the the
rates rate rate
for for for
the the the
West west West
( ( (
19 19 19
. . .
8 8 8
) ) )
, , ,
Midwest midwest Midwest
( ( (
21 21 21
. . .
8 8 8
) ) )
, , ,
and and and
Northeast northeast Northeast
( ( (
22 22 22
. . .
6 6 6
) ) )
. . .
Rates rate Rates
were were be
higher higher high
for for for
mothers mother mother
aged age age
greater greater great
than than than
or or or
equal equal equal
to to to
30 30 30
years year year
than than than
for for for
younger younger young
women women woman
; ; ;
in in in
proprietary proprietari proprietary
hospitals hospit hospital
than than than
in in in
nonprofit nonprofit nonprofit
or or or
government govern government
hospitals hospit hospital
; ; ;
in in in
hospitals hospit hospital
with with with
fewer fewer few
than than than
300 300 300
beds bed bed
than than than
in in in
larger larger large
hospitals hospit hospital
; ; ;
and and and
for for for
deliveries deliveri delivery
for for for
which which which
Blue blue Blue
Cross cross Cross
/ / /
Blue blue Blue
Shield shield Shield
* * *
and and and
other other other
private privat private
insurance insur insurance
is is be
the the the
expected expect expected
source sourc source
of of of
payment payment payment
than than than
for for for
other other other
sources sourc source
of of of
payment payment payment
( ( (
Table tabl Table
2 2 2
) ) )
. . .
The the The
same same same
pattern pattern pattern
characterized character characterize
primary primari primary
cesarean cesarean cesarean
deliveries deliveri delivery
. . .
Since sinc Since
the the the
early earli early
1970 1970 1970
s s s
, , ,
the the the
number number number
and and and
percentage percentag percentage
of of of
births birth birth
to to to
older older older
women women woman
increased increas increase
; ; ;
however howev however
, , ,
if if if
the the the
age age age
distribution distribut distribution
of of of
mothers mother mother
in in in
1991 1991 1991
had had have
remained remain remain
the the the
same same same
as as a
in in in
1986 1986 1986
, , ,
the the the
overall overal overall
cesarean cesarean cesarean
rate rate rate
in in in
1991 1991 1991
would would would
have have have
been been be
23 23 23
. . .
3 3 3
, , ,
essentially essenti essentially
the the the
same same same
as as a
the the the
23 23 23
. . .
5 5 5
observed observ observe
. . .
Based base Based
on on on
the the the
NHDS nhds NHDS
, , ,
of of of
the the the
approximately approxim approximately
4 4 4
, , ,
111 111 111
, , ,
000 000 000
live live live
births birth birth
in in in
1991 1991 1991
, , ,
an an an
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
1 1 1
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
estimated estim estimate
966 966 966
, , ,
000 000 000
( ( (
23 23 23
. . .
5 5 5
% % %
) ) )
were were be
by by by
cesarean cesarean cesarean
delivery deliveri delivery
. . .
Of of Of
these these these
, , ,
an an an
estimated estim estimated
338 338 338
, , ,
000 000 000
( ( (
35 35 35
. . .
0 0 0
% % %
) ) )
births birth birth
were were be
repeat repeat repeat
cesareans cesarean cesarean
, , ,
and and and
628 628 628
, , ,
000 000 000
( ( (
65 65 65
. . .
0 0 0
% % %
) ) )
were were be
primary primari primary
cesareans cesarean cesarean
. . .
Since sinc Since
1986 1986 1986
, , ,
approximately approxim approximately
600 600 600
, , ,
000 000 000
primary primari primary
cesareans cesarean cesarean
have have have
been been be
performed perform perform
annually annual annually
. . .
In in In
1986 1986 1986
, , ,
8 8 8
. . .
5 5 5
% % %
of of of
women women woman
who who who
had had have
a a a
previous previous previous
cesarean cesarean cesarean
delivered deliv deliver
vaginally vagin vaginally
, , ,
compared compar compare
with with with
24 24 24
. . .
2 2 2
% % %
in in in
1991 1991 1991
. . .
Of of Of
all all all
cesareans cesarean cesarean
in in in
1991 1991 1991
, , ,
35 35 35
. . .
0 0 0
% % %
were were be
associated associ associate
with with with
a a a
previous previous previous
cesarean cesarean cesarean
, , ,
30 30 30
. . .
4 4 4
% % %
with with with
dystocia dystocia dystocia
( ( (
i i i
. . .
e e e
. . .
, , ,
failure failur failure
of of of
labor labor labor
to to to
progress progress progress
) ) )
, , ,
11 11 11
. . .
7 7 7
% % %
with with with
breech breech breech
presentation present presentation
, , ,
9 9 9
. . .
2 2 2
% % %
with with with
fetal fetal fetal
distress distress distress
, , ,
and and and
13 13 13
. . .
7 7 7
% % %
with with with
all all all
other other other
specified specifi specified
complications complic complication
. . .
The the The
average averag average
hospital hospit hospital
stay stay stay
for for for
all all all
deliveries deliveri delivery
in in in
1991 1991 1991
was was be
2 2 2
. . .
8 8 8
days day day
. . .
In in In
comparison comparison comparison
, , ,
the the the
hospital hospit hospital
stay stay stay
for for for
a a a
primary primari primary
cesarean cesarean cesarean
delivery deliveri delivery
was was be
4 4 4
. . .
5 5 5
days day day
, , ,
and and and
for for for
a a a
repeat repeat repeat
cesarean cesarean cesarean
, , ,
4 4 4
. . .
2 2 2
days day day
- - -
- - -
nearly near nearly
twice twice twice
the the the
duration durat duration
for for for
VBAC vbac VBAC
deliveries deliveri delivery
( ( (
2 2 2
. . .
2 2 2
days day day
) ) )
or or or
for for for
vaginal vagin vaginal
deliveries deliveri delivery
that that that
were were be
not not not
VBACs vbac VBACs
( ( (
2 2 2
. . .
3 3 3
days day day
) ) )
. . .
In in In
1986 1986 1986
, , ,
the the the
average averag average
hospital hospit hospital
stay stay stay
for for for
all all all
deliveries deliveri delivery
was was be
3 3 3
. . .
2 2 2
days day day
, , ,
for for for
primary primari primary
cesareans cesarean cesarean
5 5 5
. . .
2 2 2
days day day
, , ,
for for for
repeat repeat repeat
cesareans cesarean cesarean
4 4 4
. . .
7 7 7
days day day
, , ,
and and and
for for for
VBAC vbac VBAC
and and and
non non non
- - -
VBAC vbac VBAC
vaginal vagin vaginal
deliveries deliveri delivery
2 2 2
. . .
7 7 7
and and and
2 2 2
. . .
6 6 6
days day day
, , ,
respectively respect respectively
. . .
Reported report Reported
by by by
: : :
Office offic Office
of of of
Vital vital Vital
and and and
Health health Health
Statistics statist Statistics
Systems system Systems
, , ,
National nation National
Center center Center
for for for
Health health Health
Statistics statist Statistics
, , ,
CDC cdc CDC
. . .
Editorial editori Editorial
Note note Note
: : :
The the The
cesarean cesarean cesarean
rate rate rate
in in in
the the the
United unit United
States state States
steadily steadili steadily
increased increas increase
from from from
1965 1965 1965
through through through
1986 1986 1986
; ; ;
however howev however
, , ,
the the the
findings find finding
in in in
this this this
report report report
indicate indic indicate
that that that
rates rate rate
have have have
been been be
stable stabl stable
since sinc since
1986 1986 1986
( ( (
3 3 3
) ) )
. . .
Because becaus Because
there there there
is is be
little littl little
evidence evid evidence
that that that
maternal matern maternal
and and and
child child child
health health health
status status status
has has have
improved improv improve
during dure during
this this this
time time time
and and and
because becaus because
cesareans cesarean cesarean
are are be
associated associ associate
with with with
an an an
increased increas increase
risk risk risk
for for for
complications complic complication
of of of
childbirth childbirth childbirth
, , ,
a a a
national nation national
health health health
objective object objective
for for for
the the the
year year year
2000 2000 2000
( ( (
4 4 4
) ) )
is is be
to to to
reduce reduc reduce
the the the
overall overal overall
cesarean cesarean cesarean
rate rate rate
to to to
15 15 15
or or or
fewer fewer few
per per per
100 100 100
deliveries deliveri delivery
and and and
the the the
primary primari primary
cesarean cesarean cesarean
rate rate rate
to to to
12 12 12
or or or
fewer fewer few
per per per
100 100 100
deliveries deliveri delivery
( ( (
objective object objective
14 14 14
. . .
8 8 8
) ) )
. . .
Postpartum postpartum Postpartum
complications complic complication
- - -
- - -
including includ include
urinary urinari urinary
tract tract tract
and and and
wound wound wound
infections infect infection
- - -
- - -
may may may
account account account
in in in
part part part
for for for
the the the
longer longer long
hospital hospit hospital
stays stay stay
for for for
cesarean cesarean cesarean
deliveries deliveri delivery
than than than
for for for
vaginal vagin vaginal
births birth birth
( ( (
5 5 5
) ) )
. . .
Moreover moreov Moreover
, , ,
the the the
prolonged prolong prolonged
hospital hospit hospital
stays stay stay
for for for
cesarean cesarean cesarean
deliveries deliveri delivery
substantially substanti substantially
increase increas increase
health health health
- - -
care care care
costs cost cost
. . .
For for For
example exampl example
, , ,
in in in
1991 1991 1991
, , ,
the the the
average averag average
costs cost cost
for for for
cesarean cesarean cesarean
and and and
vaginal vagin vaginal
deliveries deliveri delivery
were were be
$ $ $
7826 7826 7826
and and and
$ $ $
4720 4720 4720
, , ,
respectively respect respectively
. . .
The the The
additional addit additional
cost cost cost
for for for
each each each
cesarean cesarean cesarean
delivery deliveri delivery
includes includ include
$ $ $
611 611 611
for for for
physician physician physician
fees fee fee
and and and
$ $ $
2495 2495 2495
for for for
hospital hospit hospital
charges charg charge
( ( (
6 6 6
) ) )
. . .
If if If
the the the
cesarean cesarean cesarean
rate rate rate
in in in
1991 1991 1991
had had have
been been be
15 15 15
( ( (
the the the
year year year
2000 2000 2000
objective object objective
) ) )
instead instead instead
of of of
23 23 23
. . .
5 5 5
, , ,
the the the
number number number
of of of
cesarean cesarean cesarean
births birth birth
would would would
have have have
decreased decreas decrease
by by by
349 349 349
, , ,
000 000 000
( ( (
617 617 617
, , ,
000 000 000
versus versus versus
966 966 966
, , ,
000 000 000
) ) )
, , ,
resulting result result
in in in
a a a
savings save saving
of of of
more more more
than than than
$ $ $
1 1 1
billion billion billion
in in in
physician physician physician
fees fee fee
and and and
hospital hospit hospital
charges charg charge
. . .
Despite despit Despite
the the the
steady steadi steady
increase increas increase
in in in
VBAC vbac VBAC
rates rate rate
since sinc since
1986 1986 1986
, , ,
several sever several
factors factor factor
may may may
impede imped impede
progress progress progress
toward toward toward
the the the
year year year
2000 2000 2000
national nation national
health health health
objectives object objective
for for for
cesarean cesarean cesarean
delivery deliveri delivery
. . .
For for For
example exampl example
, , ,
VBAC vbac VBAC
rates rate rate
substantially substanti substantially
reflect reflect reflect
the the the
number number number
of of of
women women woman
offered offer offer
trial trial trial
of of of
labor labor labor
, , ,
which which which
has has have
been been be
increasingly increas increasingly
encouraged encourag encourage
since sinc since
1982 1982 1982
( ( (
7 7 7
) ) )
. . .
Of of Of
women women woman
who who who
are are be
offered offer offer
a a a
trial trial trial
of of of
labor labor labor
, , ,
50 50 50
% % %
- - -
70 70 70
% % %
could could could
deliver deliv deliver
vaginally vagin vaginally
( ( (
7 7 7
) ) )
- - -
- - -
a a a
level level level
already alreadi already
achieved achiev achieve
by by by
many mani many
hospitals hospit hospital
( ( (
8 8 8
) ) )
. . .
Trial trial Trial
of of of
labor labor labor
was was be
routinely routin routinely
offered offer offer
in in in
46 46 46
% % %
of of of
hospitals hospit hospital
surveyed survey survey
in in in
1984 1984 1984
( ( (
the the the
most most most
recent recent recent
year year year
for for for
which which which
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
2 2 2
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
national nation national
data data data
are are be
available avail available
) ) )
( ( (
9 9 9
) ) )
when when when
the the the
VBAC vbac VBAC
rate rate rate
( ( (
according accord accord
to to to
NHDS nhds NHDS
data data data
) ) )
was was be
5 5 5
. . .
7 7 7
% % %
. . .
The the The
year year year
2000 2000 2000
objective object objective
specifies specifi specifies
a a a
VBAC vbac VBAC
rate rate rate
of of of
35 35 35
% % %
, , ,
based base base
on on on
all all all
women women woman
who who who
had had have
a a a
prior prior prior
cesarean cesarean cesarean
, , ,
regardless regardless regardless
of of of
whether whether whether
a a a
trial trial trial
of of of
labor labor labor
was was be
attempted attempt attempt
. . .
To to To
reach reach reach
the the the
overall overal overall
cesarean cesarean cesarean
rate rate rate
goal goal goal
, , ,
however howev however
, , ,
increases increas increase
in in in
the the the
VBAC vbac VBAC
rate rate rate
will will will
need need need
to to to
be be be
combined combin combine
with with with
a a a
substantial substanti substantial
reduction reduct reduction
in in in
the the the
primary primari primary
rate rate rate
. . .
One one One
hospital hospit hospital
succeeded succeed succeed
in in in
reducing reduc reduce
the the the
rate rate rate
of of of
cesarean cesarean cesarean
delivery deliveri delivery
by by by
applying appli apply
objective object objective
criteria criteria criterion
for for for
the the the
four four four
most most most
common common common
indications indic indication
for for for
cesarean cesarean cesarean
delivery deliveri delivery
, , ,
by by by
requiring requir require
a a a
second second second
opinion opinion opinion
, , ,
and and and
by by by
instituting institut institute
a a a
peer peer peer
- - -
review review review
process process process
( ( (
10 10 10
) ) )
. . .
Other other Other
recommendations recommend recommendation
for for for
decreasing decreas decrease
cesarean cesarean cesarean
delivery deliveri delivery
rates rate rate
include includ include
eliminating elimin eliminate
incentives incent incentive
for for for
physicians physician physician
and and and
hospitals hospit hospital
by by by
equalizing equal equalize
reimbursement reimburs reimbursement
for for for
vaginal vagin vaginal
and and and
cesarean cesarean cesarean
deliveries deliveri delivery
; ; ;
public public public
dissemination dissemin dissemination
of of of
physician physician physician
- - -
and and and
hospital hospit hospital
- - -
specific specif specific
cesarean cesarean cesarean
delivery deliveri delivery
rates rate rate
to to to
increase increas increase
public public public
awareness awar awareness
of of of
differences differ difference
in in in
practices practic practice
; ; ;
and and and
addressing address address
malpractice malpractic malpractice
concerns concern concern
, , ,
which which which
may may may
be be be
an an an
important import important
factor factor factor
in in in
maintaining maintain maintain
the the the
high high high
rates rate rate
of of of
cesarean cesarean cesarean
delivery deliveri delivery
( ( (
4 4 4
) ) )
. . .
References refer References
1 1 1
. . .
Notzon notzon Notzon
FC fc FC
. . .
International intern International
differences differ difference
in in in
the the the
use use use
of of of
obstetric obstetr obstetric
interventions intervent intervention
. . .
JAMA jama JAMA
1990 1990 1990
; ; ;
263 263 263
: : :
3286 3286 3286
- - -
91 91 91
. . .
2 2 2
. . .
Graves grave Graves
EJ ej EJ
, , ,
NCHS nchs NCHS
. . .
1991 1991 1991
Summary summari Summary
: : :
National nation National
Hospital hospit Hospital
Discharge discharg Discharge
Survey survey Survey
. . .
Hyattsville hyattsvill Hyattsville
, , ,
Maryland maryland Maryland
: : :
US us US
Department depart Department
of of of
Health health Health
and and and
Human human Human
Services servic Services
, , ,
Public public Public
Health health Health
Service servic Service
, , ,
CDC cdc CDC
, , ,
1993 1993 1993
. . .
( ( (
Advance advanc Advance
data data data
no no no
. . .
227 227 227
) ) )
. . .
3 3 3
. . .
Taffel taffel Taffel
SM sm SM
, , ,
Placek placek Placek
PJ pj PJ
, , ,
Kosary kosari Kosary
CL cl CL
. . .
U u U
. . .
S s S
. . .
cesarean cesarean cesarean
section section section
rates rate rate
, , ,
1990 1990 1990
: : :
an an an
update updat update
. . .
Birth birth Birth
1992 1992 1992
; ; ;
19 19 19
: : :
21 21 21
- - -
2 2 2
. . .
4 4 4
. . .
Public public Public
Health health Health
Service servic Service
. . .
Healthy healthi Healthy
people peopl people
2000 2000 2000
: : :
national nation national
health health health
promotion promot promotion
and and and
disease diseas disease
prevention prevent prevention
objectives object objectives
- - -
- - -
full full full
report report report
, , ,
with with with
commentary commentari commentary
. . .
Washington washington Washington
, , ,
DC dc DC
: : :
US us US
Department depart Department
of of of
Health health Health
and and and
Human human Human
Services servic Services
, , ,
Public public Public
Health health Health
Service servic Service
, , ,
1991 1991 1991
; ; ;
DHHS dhhs DHHS
publication public publication
no no no
. . .
( ( (
PHS phs PHS
) ) )
91 91 91
- - -
50212 50212 50212
. . .
5 5 5
. . .
Danforth danforth Danforth
DN dn DN
. . .
Cesarean cesarean Cesarean
section section section
. . .
JAMA jama JAMA
1985 1985 1985
; ; ;
253 253 253
: : :
811 811 811
- - -
8 8 8
. . .
6 6 6
. . .
Hospital hospit Hospital
Insurance insur Insurance
Association associ Association
of of of
America america America
. . .
Table tabl Table
4 4 4
. . .
15 15 15
: : :
cost cost cost
of of of
maternity matern maternity
care care care
, , ,
physicians physician physician
' ' '
fees fee fee
, , ,
and and and
hospital hospit hospital
charges charg charge
, , ,
by by by
census census census
region region region
, , ,
based base base
on on on
Consumer consum Consumer
Price price Price
Index index Index
( ( (
1991 1991 1991
) ) )
. . .
In in In
: : :
1992 1992 1992
Source sourc Source
book book book
of of of
health health health
insurance insur insurance
data data data
. . .
Washington washington Washington
, , ,
DC dc DC
: : :
Hospital hospit Hospital
Insurance insur Insurance
Association associ Association
of of of
America america America
, , ,
1992 1992 1992
. . .
7 7 7
. . .
Committee committe Committee
on on on
Obstetrics obstetr Obstetrics
. . .
ACOG acog ACOG
committee committe committee
opinion opinion opinion
no no no
. . .
64 64 64
: : :
guidelines guidelin guideline
for for for
vaginal vagin vaginal
delivery deliveri delivery
after after after
a a a
previous previous previous
cesarean cesarean cesarean
birth birth birth
. . .
Washington washington Washington
, , ,
DC dc DC
: : :
American american American
College colleg College
of of of
Obstetricians obstetrician Obstetricians
and and and
Gynecologists gynecologist Gynecologists
, , ,
1988 1988 1988
. . .
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
3 3 3
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
8 8 8
. . .
Rosen rosen Rosen
MG mg MG
, , ,
Dickinson dickinson Dickinson
JC jc JC
. . .
Vaginal vagin Vaginal
birth birth birth
after after after
cesarean cesarean cesarean
: : :
a a a
meta meta meta
- - -
analysis analysi analysis
of of of
indicators indic indicator
for for for
success success success
. . .
Obstet obstet Obstet
Gynecol gynecol Gynecol
1990 1990 1990
; ; ;
76 76 76
: : :
865 865 865
- - -
9 9 9
. . .
9 9 9
. . .
Shiono shiono Shiono
PH ph PH
, , ,
Fielden fielden Fielden
JG jg JG
, , ,
McNellis mcnelli McNellis
D d D
, , ,
Rhoads rhoad Rhoads
GG gg GG
, , ,
Pearse pears Pearse
WH wh WH
. . .
Recent recent Recent
trends trend trend
in in in
cesarean cesarean cesarean
birth birth birth
and and and
trial trial trial
of of of
labor labor labor
rates rate rate
in in in
the the the
United unit United
States state States
. . .
JAMA jama JAMA
1987 1987 1987
; ; ;
257 257 257
: : :
494 494 494
- - -
7 7 7
. . .
10 10 10
. . .
Myers myer Myers
SA sa SA
, , ,
Gleicher gleicher Gleicher
N n N
. . .
A a A
successful success successful
program program program
to to to
lower lower lower
cesarean cesarean cesarean
- - -
section section section
rates rate rate
. . .
N n N
Engl engl Engl
J j J
Med med Med
1988 1988 1988
; ; ;
319 319 319
: : :
1511 1511 1511
- - -
6 6 6
. . .
* * *
Use use Use
of of of
trade trade trade
names name name
and and and
commercial commerci commercial
sources sourc source
is is be
for for for
identification identif identification
only onli only
and and and
does doe do
not not not
imply impli imply
endorsement endors endorsement
by by by
the the the
Public public Public
Health health Health
Service servic Service
or or or
the the the
U u U
. . .
S s S
. . .
Department depart Department
of of of
Health health Health
and and and
Human human Human
Services servic Services
. . .
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
4 4 4
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
Malaria malaria Malaria
Among among Among
U u U
. . .
S s S
. . .
Embassy embassi Embassy
Personnel personnel Personnel
- - -
- - -
Kampala kampala Kampala
, , ,
Uganda uganda Uganda
, , ,
1992 1992 1992
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
SOURCE sourc SOURCE
: : :
MMWR mmwr MMWR
42 42 42
( ( (
15 15 15
) ) )
DATE date DATE
: : :
Apr apr Apr
23 23 23
, , ,
1993 1993 1993
The the The
treatment treatment treatment
and and and
prevention prevent prevention
of of of
malaria malaria malaria
in in in
Africa africa Africa
has has have
become becom become
a a a
challenging challeng challenging
and and and
complex complex complex
problem problem problem
because becaus because
of of of
increasing increas increase
drug drug drug
resistance resist resistance
. . .
Although although Although
the the the
risk risk risk
of of of
acquiring acquir acquire
malaria malaria malaria
for for for
U u U
. . .
S s S
. . .
citizens citizen citizen
and and and
their their their
dependents depend dependent
stationed station station
overseas oversea overseas
generally general generally
has has have
been been be
low low low
, , ,
this this this
risk risk risk
varies vari vary
substantially substanti substantially
and and and
unpredictably unpredict unpredictably
. . .
During dure During
May may May
1992 1992 1992
, , ,
the the the
Office offic Office
of of of
Medical medic Medical
Services servic Services
, , ,
Department depart Department
of of of
State state State
( ( (
OMS om OMS
/ / /
DOS dos DOS
) ) )
, , ,
and and and
CDC cdc CDC
were were be
notified notifi notify
of of of
an an an
increased increas increased
number number number
of of of
malaria malaria malaria
cases case case
among among among
official offici official
U u U
. . .
S s S
. . .
personnel personnel personnel
stationed station station
in in in
Kampala kampala Kampala
, , ,
Uganda uganda Uganda
. . .
A a A
review review review
of of of
the the the
health health health
records record record
from from from
the the the
Embassy embassi Embassy
Health health Health
Unit unit Unit
( ( (
EHU ehu EHU
) ) )
in in in
Kampala kampala Kampala
indicated indic indicate
that that that
27 27 27
cases case case
of of of
malaria malaria malaria
were were be
diagnosed diagnos diagnose
in in in
official offici official
personnel personnel personnel
from from from
March march March
through through through
June june June
1992 1992 1992
compared compar compare
with with with
two two two
cases case case
during dure during
the the the
same same same
period period period
in in in
1991 1991 1991
. . .
EHU ehu EHU
, , ,
OMS om OMS
/ / /
DOS dos DOS
, , ,
and and and
CDC cdc CDC
conducted conduct conduct
an an an
investigation investig investigation
to to to
confirm confirm confirm
all all all
reported report report
malaria malaria malaria
cases case case
and and and
identify identifi identify
potential potenti potential
risk risk risk
factors factor factor
for for for
malaria malaria malaria
among among among
U u U
. . .
S s S
. . .
Embassy embassi Embassy
personnel personnel personnel
. . .
This this This
report report report
summarizes summar summarize
the the the
results result result
of of of
the the the
investigation investig investigation
. . .
Malaria malaria Malaria
blood blood blood
smears smear smear
from from from
25 25 25
of of of
the the the
27 27 27
reported report report
case case case
- - -
patients patient patient
were were be
available avail available
for for for
review review review
by by by
OMS om OMS
/ / /
DOS dos DOS
and and and
CDC cdc CDC
. . .
A a A
case case case
of of of
malaria malaria malaria
was was be
confirmed confirm confirm
if if if
the the the
slide slide slide
was was be
positive posit positive
for for for
Plasmodium plasmodium Plasmodium
sp sp sp
. . .
Of of Of
the the the
25 25 25
persons person person
, , ,
17 17 17
were were be
slide slide slide
- - -
confirmed confirm confirm
as as a
having have have
malaria malaria malaria
. . .
A a A
questionnaire questionnair questionnaire
was was be
distributed distribut distribute
to to to
all all all
persons person person
served serv serve
by by by
the the the
EHU ehu EHU
to to to
obtain obtain obtain
information inform information
about about about
residence resid residence
, , ,
activities activ activity
, , ,
use use use
of of of
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
, , ,
and and and
use use use
of of of
personal person personal
protection protect protection
measures measur measure
( ( (
i i i
. . .
e e e
. . .
, , ,
using use use
bednets bednet bednets
and and and
insect insect insect
repellents repel repellent
, , ,
having have have
window window window
and and and
door door door
screens screen screen
, , ,
and and and
wearing wear wear
long long long
sleeves sleev sleeve
and and and
pants pant pant
in in in
the the the
evening even evening
) ) )
. . .
Of of Of
the the the
157 157 157
persons person person
eligible elig eligible
for for for
the the the
survey survey survey
, , ,
128 128 128
( ( (
82 82 82
% % %
) ) )
responded respond respond
. . .
Risk risk Risk
for for for
malaria malaria malaria
was was be
not not not
associated associ associate
with with with
sex sex sex
or or or
location locat location
of of of
residence resid residence
in in in
Kampala kampala Kampala
. . .
Although although Although
the the the
risk risk risk
for for for
malaria malaria malaria
was was be
higher higher high
among among among
children children child
aged age age
less less less
than than than
or or or
equal equal equal
to to to
15 15 15
years year year
( ( (
6 6 6
/ / /
32 32 32
19 19 19
% % %
) ) )
than than than
among among among
persons person person
greater greater great
than than than
15 15 15
years year year
( ( (
11 11 11
/ / /
94 94 94
12 12 12
% % %
) ) )
, , ,
this this this
difference differ difference
was was be
not not not
significant signific significant
( ( (
relative relat relative
risk risk risk
RR rr RR
= = =
1 1 1
. . .
6 6 6
; ; ;
95 95 95
% % %
confidence confid confidence
interval interv interval
CI ci CI
= = =
0 0 0
. . .
6 6 6
- - -
4 4 4
. . .
0 0 0
) ) )
. . .
Eighty eighti Eighty
- - -
two two two
percent percent percent
of of of
the the the
cases case case
occurred occur occur
among among among
persons person person
who who who
had had have
been been be
living live live
in in in
Kampala kampala Kampala
for for for
1 1 1
- - -
5 5 5
years year year
, , ,
compared compar compare
with with with
those those those
living live live
there there there
less less less
than than than
1 1 1
year year year
. . .
Travel travel Travel
outside outsid outside
of of of
the the the
Kampala kampala Kampala
area area area
to to to
more more more
rural rural rural
settings set setting
was was be
not not not
associated associ associate
with with with
increased increas increase
risk risk risk
for for for
malaria malaria malaria
. . .
Four four Four
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
regimens regimen regimen
were were be
used use use
by by by
persons person person
who who who
participated particip participate
in in in
the the the
survey survey survey
: : :
mefloquine mefloquin mefloquine
, , ,
chloroquine chloroquin chloroquine
and and and
proguanil proguanil proguanil
, , ,
chloroquine chloroquin chloroquine
alone alon alone
, , ,
and and and
proguanil proguanil proguanil
alone alon alone
. . .
In in In
addition addit addition
, , ,
23 23 23
( ( (
18 18 18
% % %
) ) )
persons person person
who who who
responded respond respond
were were be
not not not
using use use
any ani any
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
. . .
The the The
risk risk risk
for for for
malaria malaria malaria
was was be
significantly signific significantly
lower lower low
among among among
persons person person
using use use
either either either
mefloquine mefloquin mefloquine
or or or
chloroquine chloroquin chloroquine
and and and
proguanil proguanil proguanil
( ( (
8 8 8
/ / /
88 88 88
9 9 9
% % %
) ) )
than than than
among among among
persons person person
using use use
the the the
other other other
regimens regimen regimen
or or or
no no no
prophylaxis prophylaxi prophylaxis
( ( (
9 9 9
/ / /
37 37 37
24 24 24
% % %
) ) )
( ( (
RR rr RR
= = =
0 0 0
. . .
4 4 4
; ; ;
95 95 95
% % %
CI ci CI
= = =
0 0 0
. . .
2 2 2
- - -
0 0 0
. . .
9 9 9
) ) )
. . .
Twelve twelv Twelve
persons person person
not not not
using use use
prophylaxis prophylaxi prophylaxis
reported report report
side side side
effects effect effect
or or or
fear fear fear
of of of
possible possibl possible
side side side
effects effect effect
as as a
a a a
reason reason reason
. . .
The the The
risk risk risk
for for for
malaria malaria malaria
was was be
lower lower low
among among among
persons person person
who who who
reported report report
using use use
bednets bednet bednets
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
5 5 5
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
all all all
or or or
most most most
of of of
the the the
time time time
( ( (
2 2 2
/ / /
27 27 27
7 7 7
% % %
) ) )
than than than
among among among
persons person person
who who who
sometimes sometim sometimes
or or or
rarely rare rarely
used use used
bednets bednet bednets
( ( (
15 15 15
/ / /
99 99 99
15 15 15
% % %
) ) )
( ( (
RR rr RR
= = =
0 0 0
. . .
5 5 5
; ; ;
95 95 95
% % %
CI ci CI
= = =
0 0 0
. . .
1 1 1
- - -
2 2 2
. . .
0 0 0
) ) )
. . .
The the The
risk risk risk
for for for
malaria malaria malaria
was was be
also also also
lower lower low
among among among
persons person person
who who who
consistently consist consistently
used use use
insect insect insect
repellent repel repellent
in in in
the the the
evening even evening
( ( (
0 0 0
/ / /
16 16 16
) ) )
, , ,
compared compar compare
with with with
those those those
who who who
rarely rare rarely
used use use
repellent repel repellent
( ( (
17 17 17
/ / /
110 110 110
15 15 15
% % %
) ) )
( ( (
RR rr RR
= = =
0 0 0
; ; ;
upper upper upper
95 95 95
% % %
confidence confid confidence
limit limit limit
= = =
1 1 1
. . .
2 2 2
) ) )
. . .
Risk risk Risk
for for for
malaria malaria malaria
was was be
not not not
associated associ associate
with with with
failure failur failure
to to to
have have have
window window window
or or or
door door door
screens screen screen
or or or
wear wear wear
long long long
sleeves sleev sleeve
or or or
pants pant pant
in in in
the the the
evening even evening
. . .
As as As
a a a
result result result
of of of
this this this
investigation investig investigation
, , ,
EHU ehu EHU
staff staff staff
reviewed review review
with with with
all all all
personnel personnel personnel
the the the
need need need
to to to
use use use
and and and
comply compli comply
with with with
the the the
recommended recommend recommend
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
regimens regimen regimen
. . .
EHU ehu EHU
staff staff staff
also also also
emphasized emphas emphasize
the the the
need need need
to to to
use use use
personal person personal
protection protect protection
measures measur measure
and and and
made made make
plans plan plan
to to to
obtain obtain obtain
insecticide insecticid insecticide
- - -
impregnated impregn impregnated
bednets bednet bednets
and and and
to to to
provide provid provide
window window window
and and and
door door door
screens screen screen
for for for
all all all
personnel personnel personnel
. . .
Reported report Reported
by by by
: : :
U u U
. . .
S s S
. . .
Embassy embassi Embassy
Health health Health
Unit unit Unit
, , ,
Kampala kampala Kampala
, , ,
Uganda uganda Uganda
; ; ;
Office offic Office
of of of
Medical medic Medical
Svcs svcs Svcs
, , ,
Dept dept Dept
of of of
State state State
, , ,
Washington washington Washington
, , ,
D d D
. . .
C c C
. . .
Malaria malaria Malaria
Br br Br
, , ,
Div div Div
of of of
Parasitic parasit Parasitic
Diseases diseas Diseases
, , ,
National nation National
Center center Center
for for for
Infectious infecti Infectious
Diseases diseas Diseases
, , ,
CDC cdc CDC
. . .
Editorial editori Editorial
Note note Note
: : :
In in In
Uganda uganda Uganda
, , ,
the the the
increase increas increase
in in in
malaria malaria malaria
among among among
U u U
. . .
S s S
. . .
personnel personnel personnel
was was be
attributed attribut attribute
to to to
poor poor poor
adherence adher adherence
to to to
both both both
recommended recommend recommend
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
regimens regimen regimen
and and and
use use use
of of of
personal person personal
protection protect protection
measures measur measure
during dure during
a a a
period period period
of of of
increased increas increased
malaria malaria malaria
transmission transmiss transmission
and and and
intensified intensifi intensified
chloroquine chloroquin chloroquine
resistance resist resistance
in in in
sub sub sub
- - -
Saharan saharan Saharan
Africa africa Africa
. . .
The the The
findings find finding
in in in
this this this
report report report
underscore underscor underscore
the the the
need need need
to to to
provide provid provide
initial initi initial
and and and
continued continu continued
counseling counsel counseling
regarding regard regard
malaria malaria malaria
prevention prevent prevention
for for for
persons person person
living live live
abroad abroad abroad
in in in
malaria malaria malaria
- - -
endemic endem endemic
areas area area
- - -
- - -
preventive prevent preventive
measures measur measure
that that that
are are be
also also also
important import important
for for for
short short short
- - -
term term term
travelers travel traveler
to to to
such such such
areas area area
. . .
Mefloquine mefloquin Mefloquine
is is be
an an an
effective effect effective
prophylaxis prophylaxi prophylaxis
regimen regimen regimen
in in in
Africa africa Africa
and and and
in in in
most most most
other other other
areas area area
with with with
chloroquine chloroquin chloroquine
- - -
resistant resist resistant
P p P
. . .
falciparum falciparum falciparum
; ; ;
however howev however
, , ,
in in in
some some some
areas area area
( ( (
e e e
. . .
g g g
. . .
, , ,
Thailand thailand Thailand
) ) )
, , ,
resistance resist resistance
to to to
mefloquine mefloquin mefloquine
may may may
limit limit limit
its it it
effectiveness effect effectiveness
. . .
In in In
Africa africa Africa
, , ,
the the the
efficacy efficaci efficacy
of of of
mefloquine mefloquin mefloquine
, , ,
compared compar compare
with with with
chloroquine chloroquin chloroquine
alone alon alone
, , ,
in in in
preventing prevent prevent
infection infect infection
with with with
P p P
. . .
falciparum falciparum falciparum
is is be
92 92 92
% % %
( ( (
1 1 1
) ) )
. . .
Mefloquine mefloquin Mefloquine
is is be
safe safe safe
and and and
well well well
tolerated toler tolerate
when when when
given given give
at at at
250 250 250
mg mg mg
per per per
week week week
over over over
a a a
2 2 2
- - -
year year year
period period period
. . .
The the The
risk risk risk
for for for
serious serious serious
adverse advers adverse
reactions reaction reaction
possibly possibl possibly
associated associ associate
with with with
mefloquine mefloquin mefloquine
prophylaxis prophylaxi prophylaxis
( ( (
e e e
. . .
g g g
. . .
, , ,
psychosis psychosi psychosis
and and and
convulsions convuls convulsion
) ) )
is is be
low low low
( ( (
i i i
. . .
e e e
. . .
, , ,
1 1 1
. . .
3 3 3
- - -
1 1 1
. . .
9 9 9
episodes episod episode
per per per
100 100 100
, , ,
000 000 000
users user user
2 2 2
) ) )
, , ,
while while while
the the the
risk risk risk
for for for
less less less
severe sever severe
adverse advers adverse
reactions reaction reaction
( ( (
e e e
. . .
g g g
. . .
, , ,
dizziness dizzi dizziness
, , ,
gastrointestinal gastrointestin gastrointestinal
complaints complaint complaint
, , ,
and and and
sleep sleep sleep
disturbances disturb disturbance
) ) )
is is be
similar similar similar
to to to
that that that
for for for
other other other
antimalarial antimalari antimalarial
chemoprophylactics chemoprophylact chemoprophylactics
( ( (
1 1 1
) ) )
. . .
Doxycycline doxycyclin Doxycycline
has has have
similar similar similar
prophylactic prophylact prophylactic
efficacy efficaci efficacy
to to to
mefloquine mefloquin mefloquine
, , ,
but but but
the the the
need need need
for for for
daily daili daily
dosing dose dosing
may may may
reduce reduc reduce
compliance complianc compliance
with with with
and and and
effectiveness effect effectiveness
of of of
this this this
regimen regimen regimen
( ( (
3 3 3
, , ,
4 4 4
) ) )
. . .
Chloroquine chloroquin Chloroquine
alone alon alone
is is be
not not not
effective effect effective
as as a
prophylaxis prophylaxi prophylaxis
in in in
areas area area
of of of
intense intens intense
chloroquine chloroquin chloroquine
resistance resist resistance
( ( (
e e e
. . .
g g g
. . .
, , ,
Southeast southeast Southeast
Asia asia Asia
and and and
Africa africa Africa
) ) )
. . .
In in In
Africa africa Africa
, , ,
for for for
persons person person
who who who
cannot cannot cannot
take take take
mefloquine mefloquin mefloquine
or or or
doxycycline doxycyclin doxycycline
, , ,
chloroquine chloroquin chloroquine
and and and
proguanil proguanil proguanil
is is be
an an an
alternative altern alternative
, , ,
although although although
less less less
effective effect effective
, , ,
regimen regimen regimen
. . .
Chloroquine chloroquin Chloroquine
should should should
be be be
used use use
for for for
malaria malaria malaria
prevention prevent prevention
in in in
areas area area
only onli only
where where where
chloroquine chloroquin chloroquine
- - -
resistant resist resistant
P p P
. . .
falciparum falciparum falciparum
has has have
not not not
been been be
reported report report
. . .
Country countri Country
- - -
specific specif specific
recommendations recommend recommendation
for for for
preventing prevent prevent
malaria malaria malaria
and and and
information inform information
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
6 6 6
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
on on on
the the the
dosage dosag dosage
and and and
precautions precaut precaution
for for for
malaria malaria malaria
chemoprophylaxis chemoprophylaxi chemoprophylaxis
regimens regimen regimen
are are be
available avail available
from from from
Health health Health
Information inform Information
for for for
International intern International
Travel travel Travel
, , ,
1992 1992 1992
( ( (
i i i
. . .
e e e
. . .
, , ,
" " "
yellow yellow yellow
book book book
" " "
) ) )
( ( (
5 5 5
) ) )
or or or
24 24 24
hours hour hour
a a a
day day day
by by by
telephone telephon telephone
or or or
fax fax fax
, , ,
( ( (
404 404 404
) ) )
332 332 332
- - -
4555 4555 4555
. . .
References refer References
1 1 1
. . .
Lobel lobel Lobel
HO ho HO
, , ,
Miani miani Miani
M m M
, , ,
Eng eng Eng
T t T
, , ,
et et et
al al al
. . .
Long long Long
- - -
term term term
malaria malaria malaria
prophylaxis prophylaxi prophylaxis
with with with
weekly week weekly
mefloquine mefloquin mefloquine
in in in
Peace peac Peace
Corps corp Corps
volunteers volunt volunteer
: : :
an an an
effective effect effective
and and and
well well well
tolerated toler tolerated
regimen regimen regimen
. . .
Lancet lancet Lancet
1993 1993 1993
; ; ;
341 341 341
: : :
848 848 848
- - -
51 51 51
. . .
2 2 2
. . .
World world World
Health health Health
Organization organ Organization
. . .
Review review Review
of of of
central central central
nervous nervous nervous
system system system
adverse advers adverse
events event event
related relat relate
to to to
the the the
antimalarial antimalari antimalarial
drug drug drug
, , ,
mefloquine mefloquin mefloquine
( ( (
1985 1985 1985
- - -
1990 1990 1990
) ) )
. . .
Geneva geneva Geneva
: : :
World world World
Health health Health
Organization organ Organization
, , ,
1991 1991 1991
; ; ;
publication public publication
no no no
. . .
WHO who WHO
/ / /
MAL mal MAL
/ / /
91 91 91
. . .
1063 1063 1063
. . .
3 3 3
. . .
Pang pang Pang
L l L
, , ,
Limsomwong limsomwong Limsomwong
N n N
, , ,
Singharaj singharaj Singharaj
P p P
. . .
Prophylactic prophylact Prophylactic
treatment treatment treatment
of of of
vivax vivax vivax
and and and
falciparum falciparum falciparum
malaria malaria malaria
with with with
low low low
- - -
dose dose dose
doxycycline doxycyclin doxycycline
. . .
J j J
Infect infect Infect
Dis dis Dis
1988 1988 1988
; ; ;
158 158 158
: : :
1124 1124 1124
- - -
7 7 7
. . .
4 4 4
. . .
Pang pang Pang
L l L
, , ,
Limsomwong limsomwong Limsomwong
N n N
, , ,
Boudreau boudreau Boudreau
EF ef EF
, , ,
Singharaj singharaj Singharaj
P p P
. . .
Doxycycline doxycyclin Doxycycline
prophylaxis prophylaxi prophylaxis
for for for
falciparum falciparum falciparum
malaria malaria malaria
. . .
Lancet lancet Lancet
1987 1987 1987
; ; ;
1 1 1
: : :
1161 1161 1161
- - -
4 4 4
. . .
5 5 5
. . .
CDC cdc CDC
. . .
Health health Health
information inform information
for for for
international intern international
travel travel travel
, , ,
1992 1992 1992
. . .
Atlanta atlanta Atlanta
: : :
US us US
Department depart Department
of of of
Health health Health
and and and
Human human Human
Services servic Services
, , ,
Public public Public
Health health Health
Service servic Service
, , ,
1992 1992 1992
: : :
98 98 98
; ; ;
DHHS dhhs DHHS
publication public publication
no no no
. . .
( ( (
CDC cdc CDC
) ) )
92 92 92
- - -
8280 8280 8280
. . .
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
7 7 7
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
FDA fda FDA
Approval approv Approval
of of of
Use use Use
of of of
a a a
New new New
Haemophilus haemophilus Haemophilus
b b b
Conjugate conjug Conjugate
Vaccine vaccin Vaccine
and and and
a a a
Combined combin Combined
Diphtheria diphtheria Diphtheria
- - -
Tetanus tetanus Tetanus
- - -
Pertussis pertussi Pertussis
and and and
Haemophilus haemophilus Haemophilus
b b b
Conjugate conjug Conjugate
Vaccine vaccin Vaccine
for for for
Infants infant Infants
and and and
Children children Children
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
= = =
SOURCE sourc SOURCE
: : :
MMWR mmwr MMWR
42 42 42
( ( (
15 15 15
) ) )
DATE date DATE
: : :
Apr apr Apr
23 23 23
, , ,
1993 1993 1993
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
type type type
b b b
( ( (
Hib hib Hib
) ) )
conjugate conjug conjugate
vaccines vaccin vaccine
have have have
been been be
recommended recommend recommend
for for for
use use use
in in in
infants infant infant
since sinc since
1990 1990 1990
, , ,
and and and
their their their
routine routin routine
use use use
in in in
infant infant infant
vaccination vaccin vaccination
has has have
contributed contribut contribute
to to to
the the the
substantial substanti substantial
decline declin decline
in in in
the the the
incidence incid incidence
of of of
Hib hib Hib
disease diseas disease
in in in
the the the
United unit United
States state States
( ( (
1 1 1
- - -
3 3 3
) ) )
. . .
Vaccines vaccin Vaccines
against against against
diphtheria diphtheria diphtheria
, , ,
tetanus tetanus tetanus
, , ,
and and and
pertussis pertussi pertussis
during dure during
infancy infanc infancy
and and and
childhood childhood childhood
have have have
been been be
administered administ administer
routinely routin routinely
in in in
the the the
United unit United
States state States
since sinc since
the the the
late late late
1940 1940 1940
s s s
and and and
has has have
been been be
associated associ associate
with with with
a a a
greater greater great
than than than
90 90 90
% % %
reduction reduct reduction
in in in
morbidity morbid morbidity
and and and
mortality mortal mortality
associated associ associate
with with with
infection infect infection
by by by
these these these
organisms organ organism
. . .
Because becaus Because
of of of
the the the
increasing increas increase
number number number
of of of
vaccines vaccin vaccine
now now now
routinely routin routinely
recommended recommend recommend
for for for
infants infant infant
, , ,
a a a
high high high
priority prioriti priority
is is be
the the the
development develop development
of of of
combined combin combined
vaccines vaccin vaccine
that that that
allow allow allow
simultaneous simultan simultaneous
administration administr administration
with with with
fewer fewer few
separate separ separate
injections inject injection
. . .
The the The
Food food Food
and and and
Drug drug Drug
Administration administr Administration
( ( (
FDA fda FDA
) ) )
recently recent recently
licensed licens license
two two two
new new new
products product product
for for for
vaccinating vaccin vaccinate
children children child
against against against
these these these
diseases diseas disease
: : :
1 1 1
) ) )
the the the
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccine vaccin vaccine
( ( (
tetanus tetanus tetanus
toxoid toxoid toxoid
conjugate conjug conjugate
, , ,
ActHIB acthib ActHIB
Trademark trademark Trademark
) ) )
, , ,
* * *
for for for
vaccination vaccin vaccination
against against against
Hib hib Hib
disease diseas disease
only onli only
and and and
2 2 2
) ) )
a a a
combined combin combine
diphtheria diphtheria diphtheria
and and and
tetanus tetanus tetanus
toxoids toxoid toxoid
and and and
whole whole whole
- - -
cell cell cell
pertussis pertussi pertussis
vaccine vaccin vaccine
( ( (
DTP dtp DTP
) ) )
and and and
Hib hib Hib
conjugate conjug conjugate
vaccine vaccin vaccine
( ( (
TETRAMUNE tetramun TETRAMUNE
Trademark trademark Trademark
) ) )
, , ,
a a a
combination combin combination
of of of
vaccines vaccin vaccine
formulated formul formulate
for for for
use use use
in in in
vaccinating vaccin vaccinate
children children child
against against against
diphtheria diphtheria diphtheria
, , ,
tetanus tetanus tetanus
, , ,
pertussis pertussi pertussis
, , ,
and and and
Hib hib Hib
disease diseas disease
. . .
ActHIB acthib ActHIB
Trademark trademark Trademark
On on On
March march March
30 30 30
, , ,
1993 1993 1993
, , ,
the the the
FDA fda FDA
approved approv approve
a a a
new new new
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccine vaccin vaccine
, , ,
polyribosylribitol polyribosylribitol polyribosylribitol
phosphate phosphat phosphate
- - -
tetanus tetanus tetanus
toxoid toxoid toxoid
conjugate conjug conjugate
( ( (
PRP prp PRP
- - -
T t T
) ) )
, , ,
manufactured manufactur manufacture
by by by
Pasteur pasteur Pasteur
Merieux merieux Merieux
Serum serum Serum
et et et
Vaccins vaccin Vaccins
and and and
distributed distribut distribute
as as a
ActHIB acthib ActHIB
Trademark trademark Trademark
by by by
Connaught connaught Connaught
Laboratories laboratori Laboratories
, , ,
Inc inc Inc
. . .
( ( (
Swiftwater swiftwat Swiftwater
, , ,
Pennsylvania pennsylvania Pennsylvania
) ) )
. . .
This this This
vaccine vaccin vaccine
has has have
been been be
licensed licens license
for for for
use use use
in in in
infants infant infant
in in in
a a a
three three three
- - -
dose dose dose
primary primari primary
vaccination vaccin vaccination
series seri series
administered administ administer
at at at
ages age age
2 2 2
, , ,
4 4 4
, , ,
and and and
6 6 6
months month month
. . .
Previously previous Previously
unvaccinated unvaccin unvaccinated
infants infant infant
7 7 7
- - -
11 11 11
months month month
of of of
age age age
should should should
receive receiv receive
two two two
doses dose dos
2 2 2
months month month
apart apart apart
. . .
Previously previous Previously
unvaccinated unvaccin unvaccinated
children children child
12 12 12
- - -
14 14 14
months month month
of of of
age age age
should should should
receive receiv receive
one one one
dose dose dose
. . .
A a A
booster booster booster
dose dose dose
administered administ administer
at at at
15 15 15
months month month
of of of
age age age
is is be
recommended recommend recommend
for for for
all all all
children children child
. . .
Previously previous Previously
unvaccinated unvaccin unvaccinated
children children child
15 15 15
- - -
59 59 59
months month month
of of of
age age age
should should should
receive receiv receive
a a a
single singl single
dose dose dose
and and and
do do do
not not not
require requir require
a a a
booster booster booster
. . .
More more More
than than than
90 90 90
% % %
of of of
infants infant infant
receiving receiv receive
a a a
primary primari primary
vaccination vaccin vaccination
series seri series
of of of
ActHIB acthib ActHIB
Trademark trademark Trademark
( ( (
consecutive consecut consecutive
doses dose dos
at at at
2 2 2
, , ,
4 4 4
, , ,
and and and
6 6 6
months month month
of of of
age age age
) ) )
develop develop develop
a a a
geometric geometr geometric
mean mean mean
titer titer titer
of of of
anti anti anti
- - -
Haemophilus haemophilus Haemophilus
b b b
polysaccharide polysaccharid polysaccharide
antibody antibodi antibody
greater greater great
than than than
1 1 1
ug ug ug
/ / /
mL ml mL
( ( (
4 4 4
) ) )
. . .
This this This
response respons response
is is be
similar similar similar
to to to
that that that
of of of
infants infant infant
who who who
receive receiv receive
recommended recommend recommend
series seri series
of of of
previously previous previously
licensed licens license
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccines vaccin vaccine
for for for
which which which
efficacy efficaci efficacy
has has have
been been be
demonstrated demonstr demonstrate
in in in
prospective prospect prospective
trials trial trial
. . .
Two two Two
U u U
. . .
S s S
. . .
efficacy efficaci efficacy
trials trial trial
of of of
PRP prp PRP
- - -
T t T
were were be
terminated termin terminate
early earli early
because becaus because
of of of
the the the
concomitant concomit concomitant
licensure licensur licensure
of of of
other other other
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccines vaccin vaccine
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
8 8 8
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
for for for
use use use
in in in
infants infant infant
( ( (
4 4 4
) ) )
. . .
In in In
these these these
studies studi study
, , ,
no no no
cases case case
of of of
invasive invas invasive
Hib hib Hib
disease diseas disease
were were be
detected detect detect
in in in
approximately approxim approximately
6000 6000 6000
infants infant infant
vaccinated vaccin vaccinate
with with with
PRP prp PRP
- - -
T t T
. . .
These these These
and and and
other other other
studies studi study
suggest suggest suggest
that that that
the the the
efficacy efficaci efficacy
of of of
PRP prp PRP
- - -
T t T
vaccine vaccin vaccine
will will will
be be be
similar similar similar
to to to
that that that
of of of
the the the
other other other
licensed licens licensed
Hib hib Hib
vaccines vaccin vaccine
. . .
TETRAMUNE tetramun TETRAMUNE
Trademark trademark Trademark
On on On
March march March
30 30 30
, , ,
1993 1993 1993
, , ,
the the the
FDA fda FDA
approved approv approve
a a a
combined combin combine
diphtheria diphtheria diphtheria
and and and
tetanus tetanus tetanus
toxoids toxoid toxoid
and and and
whole whole whole
- - -
cell cell cell
pertussis pertussi pertussis
vaccine vaccin vaccine
( ( (
DTP dtp DTP
) ) )
and and and
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccine vaccin vaccine
. . .
TETRAMUNE tetramun TETRAMUNE
Trademark trademark Trademark
, , ,
available avail available
from from from
Lederle lederl Lederle
- - -
Praxis praxi Praxis
Biologicals biolog Biologicals
( ( (
Pearl pearl Pearl
River river River
, , ,
New new New
York york York
) ) )
, , ,
combines combin combine
two two two
previously previous previously
licensed licens license
products product product
, , ,
DTP dtp DTP
( ( (
TRIIMMUNOL triimmunol TRIIMMUNOL
Registered regist Registered
, , ,
manufactured manufactur manufacture
by by by
Lederle lederl Lederle
Laboratories laboratori Laboratories
Pearl pearl Pearl
River river River
, , ,
New new New
York york York
) ) )
and and and
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccine vaccin vaccine
( ( (
HibTITER hibtit HibTITER
Registered regist Registered
, , ,
manufactured manufactur manufacture
by by by
Praxis praxi Praxis
Biologics biolog Biologics
, , ,
Inc inc Inc
. . .
Rochester rochest Rochester
, , ,
New new New
York york York
) ) )
. . .
This this This
vaccine vaccin vaccine
has has have
been been be
licensed licens license
for for for
use use use
in in in
children children child
aged age age
2 2 2
months month month
- - -
5 5 5
years year year
for for for
protection protect protection
against against against
diphtheria diphtheria diphtheria
, , ,
tetanus tetanus tetanus
, , ,
pertussis pertussi pertussis
, , ,
and and and
Hib hib Hib
disease diseas disease
when when when
indications indic indication
for for for
vaccination vaccin vaccination
with with with
DTP dtp DTP
vaccine vaccin vaccine
and and and
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccine vaccin vaccine
coincide coincid coincide
. . .
Based base Based
on on on
demonstration demonstr demonstration
of of of
co co co
mparable mparabl mparable
or or or
higher higher high
antibody antibodi antibody
responses respons response
to to to
each each each
of of of
the the the
components compon component
of of of
the the the
two two two
vaccines vaccin vaccine
, , ,
TETRAMUNE tetramun TETRAMUNE
Trademark trademark Trademark
is is be
expected expect expect
to to to
provide provid provide
protection protect protection
against against against
Hib hib Hib
, , ,
as as as
well well well
as as a
diphtheria diphtheria diphtheria
, , ,
tetanus tetanus tetanus
, , ,
and and and
pertussis pertussi pertussis
, , ,
equivalent equival equivalent
to to to
that that that
of of of
already alreadi already
licensed licens license
formulations formul formulation
of of of
other other other
DTP dtp DTP
and and and
Haemophilus haemophilus Haemophilus
b b b
vaccines vaccin vaccine
. . .
The the The
Advisory advisori Advisory
Committee committe Committee
for for for
Immunization immun Immunization
Practices practic Practices
( ( (
ACIP acip ACIP
) ) )
recommends recommend recommend
that that that
all all all
infants infant infant
receive receiv receive
a a a
primary primari primary
series seri series
of of of
one one one
of of of
the the the
licensed licens licensed
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccines vaccin vaccine
beginning begin begin
at at at
2 2 2
months month month
of of of
age age age
and and and
a a a
booster booster booster
dose dose dose
at at at
age age age
12 12 12
- - -
15 15 15
months month month
( ( (
5 5 5
) ) )
. . .
The the The
ACIP acip ACIP
also also also
recommends recommend recommend
that that that
all all all
infants infant infant
receive receiv receive
a a a
four four four
- - -
dose dose dose
primary primari primary
series seri series
of of of
diphtheria diphtheria diphtheria
and and and
tetanus tetanus tetanus
toxoids toxoid toxoid
and and and
pertussis pertussi pertussis
vaccine vaccin vaccine
at at at
2 2 2
, , ,
4 4 4
, , ,
6 6 6
, , ,
and and and
15 15 15
- - -
18 18 18
months month month
of of of
age age age
, , ,
and and and
a a a
booster booster booster
dose dose dose
at at at
4 4 4
- - -
6 6 6
years year year
( ( (
6 6 6
- - -
8 8 8
) ) )
. . .
A a A
complete complet complete
statement statement statement
regarding regard regard
recommendations recommend recommendation
for for for
use use use
of of of
ActHIB acthib ActHIB
Trademark trademark Trademark
and and and
TETRAMUNE tetramun TETRAMUNE
Trademark trademark Trademark
is is be
being be be
developed develop develop
. . .
Reported report Reported
by by by
: : :
Office offic Office
of of of
Vaccines vaccin Vaccines
Research research Research
and and and
Review review Review
, , ,
Center center Center
for for for
Biologics biolog Biologics
Evaluation evalu Evaluation
and and and
Research research Research
, , ,
Food food Food
and and and
Drug drug Drug
Administration administr Administration
. . .
Div div Div
of of of
Immunization immun Immunization
, , ,
National nation National
Center center Center
for for for
Prevention prevent Prevention
Svcs svcs Svcs
; ; ;
Meningitis mening Meningitis
and and and
Special special Special
Pathogens pathogen Pathogens
Br br Br
, , ,
Div div Div
of of of
Bacterial bacteri Bacterial
and and and
Mycotic mycot Mycotic
Diseases diseas Diseases
, , ,
National nation National
Center center Center
for for for
Infectious infecti Infectious
Diseases diseas Diseases
, , ,
CDC cdc CDC
. . .
References refer References
1 1 1
. . .
Adams adam Adams
WG wg WG
, , ,
Deaver deaver Deaver
KA ka KA
, , ,
Cochi cochi Cochi
SL sl SL
, , ,
et et et
al al al
. . .
Decline declin Decline
of of of
childhood childhood childhood
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
type type type
b b b
( ( (
Hib hib Hib
) ) )
disease diseas disease
in in in
the the the
Hib hib Hib
vaccine vaccin vaccine
era era era
. . .
JAMA jama JAMA
1993 1993 1993
; ; ;
269 269 269
: : :
221 221 221
- - -
6 6 6
. . .
2 2 2
. . .
Broadhurst broadhurst Broadhurst
LE le LE
, , ,
Erickson erickson Erickson
RL rl RL
, , ,
Kelley kelley Kelley
PW pw PW
. . .
Decrease decreas Decrease
in in in
invasive invas invasive
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
disease diseas disease
in in in
U u U
. . .
S s S
. . .
Army armi Army
children children child
, , ,
1984 1984 1984
through through through
1991 1991 1991
. . .
JAMA jama JAMA
1993 1993 1993
; ; ;
269 269 269
: : :
227 227 227
- - -
31 31 31
. . .
3 3 3
. . .
Murphy murphi Murphy
TV tv TV
, , ,
White white White
KE ke KE
, , ,
Pastor pastor Pastor
P p P
, , ,
et et et
al al al
. . .
Declining declin Declining
incidence incid incidence
of of of
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
type type type
b b b
disease diseas disease
since sinc since
introduction introduct introduction
of of of
vaccination vaccin vaccination
. . .
JAMA jama JAMA
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
9 9 9
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
1993 1993 1993
; ; ;
269 269 269
: : :
246 246 246
- - -
8 8 8
. . .
4 4 4
. . .
Fritzell fritzel Fritzell
B b B
, , ,
Plotkin plotkin Plotkin
S s S
. . .
Efficacy efficaci Efficacy
and and and
safety safeti safety
of of of
a a a
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
type type type
b b b
capsular capsular capsular
polysaccharide polysaccharid polysaccharide
- - -
tetanus tetanus tetanus
protein protein protein
conjugate conjug conjugate
vaccine vaccin vaccine
. . .
J j J
Pediatr pediatr Pediatr
1992 1992 1992
; ; ;
121 121 121
: : :
355 355 355
- - -
62 62 62
. . .
5 5 5
. . .
ACIP acip ACIP
. . .
Haemophilus haemophilus Haemophilus
b b b
conjugate conjug conjugate
vaccines vaccin vaccine
for for for
prevention prevent prevention
of of of
Haemophilus haemophilus Haemophilus
influenzae influenza influenzae
type type type
b b b
disease diseas disease
among among among
infants infant infant
and and and
children children child
two two two
months month month
of of of
age age age
and and and
older older old
: : :
recommendations recommend recommendation
of of of
the the the
Immunization immun Immunization
Practices practic Practices
Advisory advisori Advisory
Committee committe Committee
( ( (
ACIP acip ACIP
) ) )
. . .
MMWR mmwr MMWR
1991 1991 1991
; ; ;
40 40 40
( ( (
no no no
. . .
RR rr RR
- - -
1 1 1
) ) )
. . .
6 6 6
. . .
ACIP acip ACIP
. . .
Diphtheria diphtheria Diphtheria
, , ,
tetanus tetanus tetanus
, , ,
and and and
pertussis pertussi pertussis
- - -
- - -
recommendations recommend recommendation
for for for
vaccine vaccin vaccine
use use use
and and and
other other other
preventive prevent preventive
measures measur measure
: : :
recommendations recommend recommendation
of of of
the the the
Immunization immun Immunization
Practices practic Practices
Advisory advisori Advisory
Committee committe Committee
( ( (
ACIP acip ACIP
) ) )
. . .
MMWR mmwr MMWR
1991 1991 1991
; ; ;
40 40 40
( ( (
no no no
. . .
RR rr RR
- - -
10 10 10
) ) )
. . .
7 7 7
. . .
ACIP acip ACIP
. . .
Pertussis pertussi Pertussis
vaccination vaccin vaccination
: : :
acellular acellular acellular
pertussis pertussi pertussis
vaccine vaccin vaccine
for for for
reinforcing reinforc reinforce
and and and
booster booster booster
use use use
- - -
- - -
supplementary supplementari supplementary
ACIP acip ACIP
statement statement statement
: : :
recommendations recommend recommendation
of of of
the the the
Immunization immun Immunization
Practices practic Practices
Advisory advisori Advisory
Committee committe Committee
( ( (
ACIP acip ACIP
) ) )
. . .
MMWR mmwr MMWR
1992 1992 1992
; ; ;
41 41 41
( ( (
no no no
. . .
RR rr RR
- - -
1 1 1
) ) )
. . .
8 8 8
. . .
ACIP acip ACIP
. . .
Pertussis pertussi Pertussis
vaccination vaccin vaccination
: : :
acellular acellular acellular
pertussis pertussi pertussis
vaccine vaccin vaccine
for for for
the the the
fourth fourth fourth
and and and
fifth fifth fifth
doses dose dos
of of of
the the the
DTP dtp DTP
series seri series
- - -
- - -
update updat update
to to to
supplementary supplementari supplementary
ACIP acip ACIP
statement statement statement
: : :
recommendations recommend recommendation
of of of
the the the
Immunization immun Immunization
Practices practic Practices
Advisory advisori Advisory
Committee committe Committee
( ( (
ACIP acip ACIP
) ) )
. . .
MMWR mmwr MMWR
1992 1992 1992
; ; ;
41 41 41
( ( (
no no no
. . .
RR rr RR
- - -
15 15 15
) ) )
. . .
* * *
Use use Use
of of of
trade trade trade
names name name
and and and
commercial commerci commercial
sources sourc source
is is be
for for for
identification identif identification
only onli only
and and and
does doe do
not not not
imply impli imply
endorsement endors endorsement
by by by
the the the
Public public Public
Health health Health
Service servic Service
or or or
the the the
U u U
. . .
S s S
. . .
Department depart Department
of of of
Health health Health
and and and
Human human Human
Services servic Services
. . .
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
10 10 10
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
Dental dental Dental
News news News
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
: : :
International intern International
Workshop workshop Workshop
Explores explor Explores
Oral oral Oral
Manifestations manifest Manifestations
of of of
HIV hiv HIV
Infection infect Infection
NIDR nidr NIDR
Research research Research
Digest digest Digest
written written write
by by by
Jody jodi Jody
Dove dove Dove
March march March
1993 1993 1993
National nation National
Institute institut Institute
of of of
Dental dental Dental
Research research Research
At at At
the the the
Second second Second
International intern International
Workshop workshop Workshop
on on on
the the the
Oral oral Oral
Manifestations manifest Manifestations
of of of
HIV hiv HIV
Infection infect Infection
, , ,
held held hold
January januari January
31 31 31
- - -
February februari February
3 3 3
in in in
San san San
Francisco francisco Francisco
, , ,
participants particip participant
explored explor explore
issues issu issue
related relat relate
to to to
the the the
epidemiology epidemiolog epidemiology
, , ,
basic basic basic
molecular molecular molecular
virology virolog virology
, , ,
mucosal mucos mucosal
immunology immunolog immunology
, , ,
and and and
oral oral oral
clinical clinic clinical
presentations present presentation
of of of
HIV hiv HIV
infection infect infection
. . .
The the The
workshop workshop workshop
was was be
organized organ organize
by by by
Dr dr Dr
. . .
John john John
Greenspan greenspan Greenspan
and and and
Dr dr Dr
. . .
Deborah deborah Deborah
Greenspan greenspan Greenspan
of of of
the the the
Department depart Department
of of of
Stomatology stomatolog Stomatology
, , ,
School school School
of of of
Dentistry dentistri Dentistry
, , ,
University univers University
of of of
California california California
, , ,
San san San
Francisco francisco Francisco
. . .
An an An
international intern international
steering steer steering
committee committe committee
and and and
scientific scientif scientific
program program program
committee committe committee
provided provid provide
guidance guidanc guidance
. . .
The the The
conference confer conference
drew drew draw
more more more
than than than
260 260 260
scientists scientist scientist
from from from
39 39 39
countries countri country
, , ,
including includ include
Asia asia Asia
, , ,
Africa africa Africa
, , ,
Europe europ Europe
, , ,
Central central Central
America america America
, , ,
South south South
America america America
, , ,
as as as
well well well
as as a
the the the
United unit United
States state States
and and and
Canada canada Canada
. . .
Support support Support
tor tor tor
the the the
workshop workshop workshop
was was be
provided provid provide
by by by
the the the
National nation National
Institute institut Institute
of of of
Dental dental Dental
Research research Research
, , ,
the the the
National nation National
Cancer cancer Cancer
Institute institut Institute
, , ,
the the the
National nation National
Institute institut Institute
of of of
Allergy allergi Allergy
and and and
Infectious infecti Infectious
Diseases diseas Diseases
, , ,
the the the
NIH nih NIH
Office offic Office
of of of
AIDS aid AIDS
Research research Research
, , ,
and and and
the the the
Procter procter Procter
and and and
Gamble gambl Gamble
Company compani Company
. . .
Among among Among
the the the
topics topic topic
discussed discuss discuss
were were be
: : :
the the the
epidemiology epidemiolog epidemiology
of of of
HIV hiv HIV
lesions lesion lesion
; ; ;
ethics ethic ethic
, , ,
professional profession professional
responsibility respons responsibility
, , ,
and and and
public public public
policy polici policy
; ; ;
occupational occup occupational
issues issu issue
; ; ;
provision provis provision
of of of
oral oral oral
care care care
to to to
the the the
HIV hiv HIV
- - -
positive posit positive
population popul population
; ; ;
salivary salivari salivary
HIV hiv HIV
transmission transmiss transmission
and and and
mucosal mucos mucosal
immunity immun immunity
; ; ;
opportunistic opportunist opportunistic
infections infect infection
; ; ;
pediatric pediatr pediatric
HIV hiv HIV
infection infect infection
; ; ;
and and and
women women woman
' ' '
s s s
issues issu issue
. . .
Recommendations recommend Recommendations
Recommendations recommend Recommendations
emerged emerg emerge
from from from
the the the
workshop workshop workshop
to to to
define defin define
the the the
association associ association
between between between
the the the
appearance appear appearance
of of of
oral oral oral
lesions lesion lesion
and and and
rate rate rate
of of of
progression progress progression
of of of
HIV hiv HIV
, , ,
to to to
establish establish establish
a a a
universal univers universal
terminology terminolog terminology
for for for
HIV hiv HIV
- - -
associated associ associate
oral oral oral
lesions lesion lesion
, , ,
to to to
look look look
for for for
more more more
effective effect effective
treatments treatment treatment
for for for
oral oral oral
manifestations manifest manifestation
, , ,
to to to
expand expand expand
molecular molecular molecular
biology biolog biology
studies studi study
to to to
understand understand understand
the the the
relationship relationship relationship
between between between
HIV hiv HIV
infection infect infection
and and and
common common common
oral oral oral
lesions lesion lesion
, , ,
and and and
to to to
study studi study
the the the
effects effect effect
of of of
HIV hiv HIV
therapy therapi therapy
on on on
oral oral oral
lesions lesion lesion
. . .
Epidemiology epidemiolog Epidemiology
Since sinc Since
the the the
First first First
International intern International
Workshop workshop Workshop
on on on
Oral oral Oral
Manifestations manifest Manifestations
of of of
HIV hiv HIV
Infection infect Infection
was was be
convened conven convene
five five five
years year year
ago ago ago
, , ,
the the the
epidemiology epidemiolog epidemiology
of of of
HIV hiv HIV
infection infect infection
has has have
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
11 11 11
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
radically radic radically
changed chang change
. . .
In in In
1988 1988 1988
, , ,
HIV hiv HIV
infection infect infection
was was be
detected detect detect
and and and
reported report report
largely larg largely
in in in
homosexual homosexu homosexual
and and and
bisexual bisexu bisexual
males male male
, , ,
intravenous intraven intravenous
drug drug drug
users user user
, , ,
and and and
hemophiliacs hemophiliac hemophiliac
. . .
Today today Today
, , ,
more more more
HIV hiv HIV
infection infect infection
is is be
seen seen see
in in in
heterosexual heterosexu heterosexual
males male male
and and and
females femal female
and and and
in in in
children children child
and and and
adolescents adolesc adolescent
. . .
While while While
the the the
predominant predomin predominant
impact impact impact
of of of
HIV hiv HIV
infection infect infection
has has have
been been be
felt felt felt
in in in
Africa africa Africa
, , ,
a a a
major major major
increase increas increase
in in in
infection infect infection
rate rate rate
is is be
being be be
seen seen see
in in in
Southeast southeast Southeast
Asia asia Asia
as as as
well well well
. . .
Five five Five
hundred hundr hundred
thousand thousand thousand
cases case case
have have have
been been be
reported report report
to to to
date date date
in in in
this this this
region region region
and and and
more more more
are are be
appearing appear appear
all all all
the the the
time time time
. . .
Researchers research Researchers
are are be
continuing continu continue
to to to
document document document
the the the
epidemiology epidemiolog epidemiology
of of of
oral oral oral
lesions lesion lesion
such such such
as as a
hairy hairi hairy
leukoplakia leukoplakia leukoplakia
and and and
candidiasis candidiasi candidiasis
. . .
They they They
also also also
are are be
beginning begin begin
to to to
explore explor explore
the the the
relationships relationship relationship
between between between
specific specif specific
oral oral oral
lesions lesion lesion
and and and
HIV hiv HIV
disease diseas disease
progression progress progression
and and and
prognosis prognosi prognosis
. . .
Social social Social
/ / /
political polit political
Issues issu Issues
Discussion discuss Discussion
on on on
the the the
social social social
and and and
political polit political
implications implic implication
of of of
HIV hiv HIV
infection infect infection
focused focus focus
on on on
changing chang change
the the the
public public public
' ' '
s s s
attitude attitud attitude
that that that
AIDS aid AIDS
is is be
retribution retribut retribution
for for for
indiscriminate indiscrimin indiscriminate
sexual sexual sexual
behavior behavior behavior
and and and
drug drug drug
use use use
. . .
Speakers speaker Speakers
also also also
addressed address address
health health health
care care care
delivery deliveri delivery
for for for
HIV hiv HIV
- - -
infected infect infected
patients patient patient
, , ,
and and and
the the the
need need need
to to to
educate educ educate
the the the
public public public
about about about
what what what
AIDS aid AIDS
is is be
, , ,
and and and
how how how
it it it
is is be
acquired acquir acquire
. . .
Saliva saliva Saliva
and and and
Salivary salivari Salivary
Glands gland Glands
Conference confer Conference
speakers speaker speaker
described describ describe
transmission transmiss transmission
issues issu issue
and and and
the the the
HIV hiv HIV
- - -
inhibitory inhibitori inhibitory
activity activ activity
of of of
saliva saliva saliva
, , ,
the the the
strength strength strength
of of of
which which which
varies vari varies
among among among
the the the
different differ different
salivary salivari salivary
secretions secret secretion
. . .
Whole whole Whole
saliva saliva saliva
has has have
a a a
greater greater great
inhibitory inhibitori inhibitory
effect effect effect
than than than
submandibular submandibular submandibular
secretions secret secretion
, , ,
which which which
in in in
turn turn turn
have have have
a a a
greater greater great
inhibitory inhibitori inhibitory
effect effect effect
than than than
parotid parotid parotid
secretions secret secretion
. . .
Research research Research
has has have
shown shown show
that that that
at at at
least least least
two two two
mechanisms mechan mechanism
are are be
responsible respons responsible
for for for
salivary salivari salivary
inhibitory inhibitori inhibitory
activity activ activity
. . .
They they They
attributed attribut attribute
the the the
HIV hiv HIV
- - -
inhibitory inhibitori inhibitory
effect effect effect
of of of
saliva saliva saliva
to to to
the the the
1 1 1
) ) )
aggregation aggreg aggregation
/ / /
agglutination agglutin agglutination
of of of
HIV hiv HIV
by by by
saliva saliva saliva
, , ,
which which which
may may may
both both both
promote promot promote
clearance clearanc clearance
of of of
virus virus virus
and and and
prevent prevent prevent
it it it
reaching reach reach
a a a
target target target
cell cell cell
, , ,
and and and
2 2 2
) ) )
direct direct direct
effects effect effect
on on on
the the the
virus virus virus
or or or
target target target
cells cell cell
. . .
Other other Other
topics topic topic
discussed discuss discuss
were were be
the the the
manifestation manifest manifestation
of of of
salivary salivari salivary
gland gland gland
disease diseas disease
in in in
HIV hiv HIV
- - -
infected infect infected
persons person person
and and and
current current current
research research research
on on on
oral oral oral
mucosal mucos mucosal
immunity immun immunity
. . .
Pediatric pediatr Pediatric
Issues issu Issues
Pediatric pediatr Pediatric
AIDS aid AIDS
recently recent recently
has has have
emerged emerg emerge
as as a
an an an
area area area
of of of
intense intens intense
interest interest interest
. . .
With with With
early earli early
and and and
accurate accur accurate
diagnosis diagnosi diagnosis
and and and
proper proper proper
treatment treatment treatment
, , ,
the the the
life life life
expectancy expect expectancy
of of of
HIV hiv HIV
- - -
infected infect infected
children children child
has has have
tripled tripl triple
. . .
The the The
prevention prevent prevention
of of of
transmission transmiss transmission
of of of
HIV hiv HIV
from from from
mother mother mother
to to to
child child child
may may may
be be be
possible possibl possible
in in in
many mani many
cases case case
, , ,
particularly particular particularly
if if if
the the the
mother mother mother
' ' '
s s s
sero sero sero
- - -
status status status
is is be
known known know
prior prior prior
to to to
giving give give
birth birth birth
. . .
Periodontal periodont Periodontal
and and and
Gingival gingiv Gingival
Tissue tissu Tissue
Disease diseas Disease
HICNet hicnet HICNet
Medical medic Medical
Newsletter newslett Newsletter
Page page Page
12 12 12
Volume volum Volume
6 6 6
, , ,
Number number Number
11 11 11
April april April
25 25 25
, , ,
1993 1993 1993
Oral oral Oral
health health health
researchers research researcher
continue continu continue
to to to
explore explor explore
periodontal periodont periodontal
diseases diseas disease
and and and
gingivitis gingiv gingivitis
found found find
in in in
individuals individu individual
with with with
HIV hiv HIV
infection infect infection
. . .
Recommendations recommend Recommendations
made made make
at at at
the the the
workshop workshop workshop
include includ include
the the the
standardization standard standardization
of of of
terminology terminolog terminology
, , ,
refinement refin refinement
of of of
diagnostic diagnost diagnostic
markers marker marker
, , ,
standardization standard standardization
of of of
study studi study
design design design
, , ,
and and and
proper proper proper
consideration consider consideration
of of of
confounding confound confound
variables variabl variable
resulting result result
from from from
periodontal periodont periodontal
therapy therapi therapy
. . .
Occupational occup Occupational
and and and
Treatment treatment Treatment
Issues issu Issues
Occupational occup Occupational
issues issu issue
surrounding surround surround
the the the
treatment treatment treatment
of of of
HIV hiv HIV
- - -
infected infect infected
individuals individu individual
and and and
treatment treatment treatment
rendered render render
by by by
HIV hiv HIV
- - -
infected infect infect
health health health
care care care
professionals profession professional
still still still
command command command
considerable consider considerable
attention attent attention
. . .
Factors factor Factors
under under under
consideration consider consideration
include includ include
the the the
cost cost cost
/ / /
benefit benefit benefit
of of of
HIV hiv HIV
testing test test
, , ,
patient patient patient
- - -
to to to
- - -
health health health
care care care
provider provid provider
transmission transmiss transmission
of of of
HIV hiv HIV
infection infect infection
and and and
the the the
reverse revers reverse
, , ,
and and and
the the the
use use use
of of of
mainstream mainstream mainstream
versus versus versus
dedicated dedic dedicate
facilities facil facility
for for for
the the the
treatment treatment treatment
of of of
HIV hiv HIV
- - -
infected infect infected
patients patient patient
. . .
Conference confer Conference
participants particip participant
anticipate anticip anticipate
that that that
a a a
third third third
International intern International
Workshop workshop Workshop
on on on
the the the
Oral oral Oral
Manifestations manifest Manifestations
of of of
HIV hiv HIV
Infection infect Infection
will will will
be be be
held held hold
in in in
five five five
years year year
or or or
less less less
. . .
Proceedings proceed Proceedings
from from from
the the the
second second second
workshop workshop workshop
will will will
be be be
published publish publish
by by by
the the the
Quintessence quintess Quintessence
Company compani Company
in in in
late late late
1993 1993 1993
. . .
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
end end end
of of of
part part part
1 1 1
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
Internet internet Internet
: : :
david david david
@ @ @
stat stat stat
. . .
com com com
FAX fax FAX
: : :
+ + +
1 1 1
( ( (
602 602 602
) ) )
451 451 451
- - -
1165 1165 1165
Bitnet bitnet Bitnet
: : :
ATW atw ATW
1 1 1
H h H
@ @ @
ASUACAD asuacad ASUACAD
FidoNet fidonet FidoNet
= = =
> > >
1 1 1
: : :
114 114 114
/ / /
15 15 15
Amateur amateur Amateur
Packet packet Packet
ax ax ax
25 25 25
: : :
wb wb wb
7 7 7
tpy tpi tpy
@ @ @
wb wb wb
7 7 7
tpy tpi tpy
. . .
az az az
. . .
usa usa usa
. . .
na na na
